Sorafenib/Nexavar Correct Usage and Dosage Guide

Sorafenib/Nexavar (Sorafenib) is a multi-target tyrosine kinase inhibitor that is widely used in the treatment of liver cancer, renal cell carcinoma and some thyroid cancers. As an oral targeted drug, the standard usage of sorafenib is usually 400 mg twice daily, that is, a total of 800 mg per day, taken approximately 12 hours apart. However, the actual dosage needs to be adjusted based on the patient's individual tolerance and physician evaluation. This drug should be taken on an empty stomach, that is, at least 1 hour before or 2 hours after a meal to ensure optimal absorption and avoid food interfering with the efficacy of the drug.

During the medication process, patients should strictly follow the doctor's instructions and should not increase or decrease the dosage without authorization. Some patients may experience side effects such as hand-foot syndrome, rash, diarrhea, or high blood pressure in the early stages of treatment. If obvious discomfort occurs, the doctor should be informed in time, and the dosage may need to be adjusted or supportive treatment measures may be required. For patients who are taking sorafenib for the first time, doctors usually closely monitor physiological indicators such as liver function, blood pressure, and electrolytes to ensure the safety and efficacy of the drug. If a patient experiences serious adverse reactions, the doctor may recommend suspending the medication and restarting at a lower dose after symptoms subside.

In addition, sorafenib may interact with other drugs, especially when used in combination with certain antibiotics, antifungals or anti-epileptic drugs, which will affect drug metabolism. Therefore, a list of all drugs you are taking should be truthfully provided to your doctor before use. During the entire treatment process, continuous monitoring of tumor changes and disease progression is also an important basis for judging whether to continue taking sorafenib. Patients should cooperate with regular imaging examinations and tumor marker assessments so that doctors can make individualized treatment decisions.

Reference materials:https://www.nexavar.com/